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The hypothesis of this study is: HSV-1 infection of murine fibroblasts and 
keratinocytes inhibits expression of MHC class I molecules during first 24 hours of 
infection. IFN-γ pretreatment of fibroblasts protected the cells from virus-induced 
inhibition of MHC class I expression, but did not protect keratinocytes. Herpesviruses are 
known for their ability to establish persistent infections. Herpesviruses exert many 
different ways to suppress host defense mechanisms.  One such way is by down 
regulating expression of the major histocompatibility complex I (MHC I) molecules in 
infected cells. Epidermal cells such as keratinocytes are the major sites for herpes 
simplex virus type 1 (HSV-1) replication both in active primary and recurring herpes 
infection. In this study, murine keratinocyte cell lines (HEL-30 & PAM-212) were shown 
to be refractory to IFN-γ induction of an MHC class I expression to HSV-1 infection, 
while IFN-γ did induce MHC class I expression in murine fibroblast cell lines (L929 & 
A2R1). In the current study, using Image J analyses of immunocytochemical data, MHC 
class I expression decreased at 6, 12, and 24 hours after infection of L929 and A2R1 
fibroblasts (p< 0.001) with HSV-1 infection.  The effect of IFN- on expression of MHC 
I molecules was evaluated in HSV-1-infected murine keratinocytes and fibroblasts at 24 
hours after infection. In other studies, IFN- was found to protect the murine fibroblast 
cell line, L929 from the cytopathic effect of HSV-1 but was unable to protect murine 
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keratinocyte cell lines (HEL-30 and PAM-212) from HSV-1 induced cytopathic effects 
(Frey et al., 2009). Immunofluorescent staining for expression of  MHC class I molecules 
in IFN- treated and HSV-1 infected cells was performed using immunocytochemistry 
and flow cytometry.  Only the fibroblast cell lines could be examined by both methods.  
Significant increases (p < 0.001) in expression of MHC class I molecules were seen in 
both HSV-1 infected fibroblast cell lines after treatment with IFN- using both 
immunocytochemistry and flow cytometry.  Since keratinocytes grow in clusters, 
immunocytochemistry was not used to evaluate their expression of the MHC class I 
molecules in HSV-1-infected and IFN- treated cells.  Keratinocytes could be gently 
removed from the culture using cell stripper solution, and were then examined by flow 
cytometry for expression of MHC class I molecules.  In both keratinocyte cell lines, 
significant decreases in expression levels of MHC class I molecules over baseline levels 
(p<0.001) were observed after HSV-1 infection and IFN- treatment.  
In the current study, HSV-1 infection of murine fibroblasts and keratinocytes 
inhibited expression of MHC class I molecules during first 24 hours of infection. IFN-γ 
pretreatment of fibroblasts protected them from virus-induced inhibition of MHC class I 
expression, but did not protect keratinocytes.  The refractoriness of keratinocytes to IFN-
γ might be due to the expression of suppressor of cytokine synthesis-1 (SOCS-1) during 
HSV-1 infection as observed by the Frey et al., (2009).  
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Alpha herpes viruses constitute the largest subfamily of the Herpes viridae which 
will cause infections to humans and animals. The human alpha herpes viruses, herpes 
simplex viruses type 1 (HSV-1), type 2 (HSV-2) and varicella-zoster virus (VZV) are 
antigenitically distinct.  HSV-1 can be diagnosed through oral blisters and HSV-2 
through genital ulcers (Pena et al., 2010). Historically, HSV-1 was found infrequently in 
genital HSV infections, but recent studies show an increase in prevalence up to 60% 
(Marshall et al., 2001). HSV-1 also leads to infections like ocular herpes, which range 
from mild to severe stromal keratitis symptoms. HSV-1 may also result in blindness, 
encephalitis, aseptic meningitis and atypical pneumonia (Whitley, 2001). 
HSV-1 is a double stranded DNA virus that causes both productive and latent 
infections. Latent infection can persist in the body throughout the life of the host. HSV-1 
hides from the immune system by residing latently in the cell bodies of nerves. When 
activated, the virus will be transported to the skin from the nerves where they replicate 
and cause sores (Norkin, 2010). The HSV virion (Figure 1A) is comprised of the viral 
double-stranded DNA, an icosahedral capsid shell, a tegument layer containing numerous 
viral proteins and a lipid membrane envelope studded with viral glycoproteins. The HSV  
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genome (Figure 1B) is composed of long (L) and short (S) components with a unique 
region (U) flanked by inverted repeat regions (Taylor et al., 2002). 
 
 
Figure 1: HSV virion structure and genome organization. The HSV virion (A), the 
major structural components of the virion can be seen in an EM photograph (right) 
where the viral envelope is ruptured and folded back. The HSV genome (B) is 
organized into two components, long (L) and short (S). Each component contains a 
unique region (U) flanked by inverted repeat regions and are linked to generate a 





HSV-1 utilizes glycoprotein-receptor complexes gB, gC, gD, gH, and gL during 
host entry and these are essential for host cell entry (Figure 2A) (Shukla et al., 2001).  
Initial contact and binding is made by the gC with the heparan sulfate (HS) proteoglycans 
on host cell surface in case of fibroblasts (Lilly et al.,1998). HSV-1 attaches using 
extracellular receptors in non-neuronal cells through filopodia-like membrane protrusions 
and reaches the cell for internalization (Figure 2B) (Oh et al., 2010).  Keratinocytes are 
the major sites of HSV-1 replication in primary or recurring herpes infection 
(Cunningham et al., 2006). In particular, infection of keratinocytes occurs through 
endocytic processes (Figure 2B) (Nicola et al., 2005). Once fusion of the virus is 
completed, the viral genome enters the nucleus through the nuclear pore complex (Shahin 
et al., 2006). During subsequent lytic infection, the virus is able to move from the initial 
site of infection through the underlying strata to reach the innervating neurons (Wharton 
et al., 1995). Once virus traverses through neuron it establishes a latent state which is 




Figure 2: Genomic distribution of HSV glycoproteins involved in viral entry and 
cell-to-cell spread. A. Glycoprotein genes required for HSV-1 entry and spread. 
HSV contains a 152-kb double-stranded linear DNA genome encoding over 80 viral 
genes that are arranged as unique long (UL) and unique short (US) segments 
flanked by inverted repeat sequences (boxes). The inverted repeats contain 
sequences required for cleavage/packaging of the viral genome. B. Pathways of HSV 
entry into cells. (I)  penetration by viral envelope fusion at the plasma membrane 
and (II) endocytosis (Adapted from Sarah et al., 2012). 
 
The immune system plays a major role in protecting the body from infection. The 
system is divided into two major branches: the innate immune system and the adaptive 
immune system. Innate immune system is the first line of defense when the body is 
exposed to invading microbes. Adaptive immune system is only found in vertebrates. 
Assembly of antigen-binding molecules specific for structures of intracellular or 




Two types of cells present in the adaptive immune system are B cells and T cells. 
B cells are involved in humoral immune response and carry antigen-specific B cell 
receptors on their cell surface.  In the presence of infection, B cells will be activated and 
release antibodies that bind to the antigen. T cells recognize antigenic peptides presented 
on the surface of host cells through major histocompatibility complex (MHC) molecules 
(Rupert and Robert, 2004). There are two types of MHC molecules. MHC class I 
molecules are found on all nucleated cell bodies and present peptides to the CD8
+
 
cytotoxic T cells that kill the non-self-peptides from the pathogens. MHC class II 
molecules present peptides to the CD4
+
 T helper cells; these stimulate the B cells 
resulting in production of antibodies (Mellman and Steinman, 2001). 
Major histocompatibility complex (MHC) class I molecules are becoming 
important targets for the virus during immune evasion. Down regulation of MHC class I 
expression can attenuate the CD8 T-cell-mediated recognition of infected cells. Herpes 
virus family members down regulate the MHC class I presentation by different 
mechanisms (Mark et al., 2004). Precisely, HSV-1 produces two proteins that help in 
inhibiting antigen attack. The first protein is a viral host shutoff protein that helps in 
preventing antigen production by targeting mRNA. The second protein ICP47 acts 
directly on the complex called TAP1/2. This complex helps in transport of antigens from 
cytosol to the endoplasmic reticulum (ER). Thus, when ICP47 attacks the TAP1/2 
complex, then the transportation of antigens to ER will be stopped thereby affecting 
further functions (Mark et al., 2004). The transporter associated with antigen processing 
(TAP) is essential for peptide delivery from the cytosol into the lumen of the ER.  These 
peptides are loaded to MHC class I molecules. The loaded MHC class I vacate the ER 
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and present the antigen on the cell surface of cytotoxic T cells (CTLs). Interaction of 
cytotoxic T cells leads to the elimination of virus infected cells (Figure 3) (Rupert and 
Robert, 2004). 
Raftery et al., proposed a mechanism underlying fratricide in active HSV-1 
infections. During HSV-1 infection on epithelial cells, free virions can bind to herpes 
virus entry mediator (HVEM) molecule and infect the CTLs. These CTLs, when they 
recognize the viral antigen will up regulate the CD95L. During this time, HSV-1 blocks 
AICD and down regulates MHC class I molecules. This overall mechanism makes CTLs 
more susceptible to infection than epithelial cells (Figure 4) (Raftery et al., 1999). 
 
 
Figure 3: Overview of the MHC I antigen-processing pathway- TAP (Transporter 
Associated with antigen Processing), ER (Endoplasmic Reticulum), MHC I (Major 
Histocompatibility Complex), BiP (Immunoglobulin Binding Protein), ß2m, ß2-







Figure 4: HSV1-induced fratricide of antiviral CTLs as a mechanism of viral 
immune evasion. Antiviral CTLs activated in the draining lymph nodes enter the 
epithelial lesions, where they are infected by HSV1 virions 1. Due to inefficient 
activity of the TAP (Transporter Associated with antigen Processing) blocker in T 
lymphocytes, viral antigens are presented via the MHC class I molecules and 
recognized by neighboring CTLs 2. In addition, HSV1 lifts the block for CD95-
mediated death signals, resulting in fratricide (Adapted from Raftery et al., 1999). 
 
In the current study IFN-γ was used to rescue the murine fibroblast and 
keratinocyte cell lines from HSV-1 induced MHC class I down regulation. IFN-γ plays a 
major antiviral role during HSV1 infection. It was observed that IFN-γ produced by 
CD8+ T cells is effective against HSV-1 infection in adaptive immunity. IFN-γ signaling 
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begins with interaction of IFN-γ with an IFN receptor complex consisting of two 
IFNGR1 molecules and two IFNGR2 molecules (Waiboci et al., 2007). The C-terminus 
of IFN-γ consists of a nuclear localization sequence (NLS), which plays an important role 
in binding of IFN-γ to IFNGRs. Endocytosis of IFN-γ into the cell occurs with an 
interaction of IFN-γ NLS domain to IFNGR1. This induces JAK2 auto phosphorylation 
on tyrosine residues. Auto phosphorylation of JAK2 induces activation and 
phosphorylation of STAT1, then STAT1 delivers a signal to the nucleus. IFNs (type I and 
II) select their specific pair of Janus Kinase (JAK), signal transduction and transcription 
(STAT) group for translocation of signal to the nucleus (Yokota et al., 2005). In case of 
HSV-1 infection, IFN-γ in the trigeminal ganglia plays a key role in controlling the 
infection by inhibition of reactivation and inhibition of ICP0 (Minami et al., 2002). 
SOCS-1 is an inhibitor of JAK which in turn down regulates IFN-γ expression in 
keratinocytes (Frey et al., 2009). 
SOCS (Suppressor of Cytokine Signaling) proteins are a family of 8 members; 
SOCS-1, SOCS-2, SOCS-3, SOCS-4, SOCS-5, SOCS-6, SOCS-7 and cytokine-inducible 
SH2 protein. SOCS has a kinase inhibitory region (KIR) and SRC Homology 2 (SH2) 
domains that plays an important role in binding of SOCS-1 to JAK2. When the KIR 
region binds to JAK2 tyrosine residue, inhibits the autophosphorylation of STAT1a. 
Inhibition of STAT1a autophosphorylation leads to blockage of the IFN-γ signaling 
pathway. By the use of SOCS mimetic or Tyrosine kinase inhibitory peptide (Tkip) 
during HSV-1 infection, it was observed that peptide mimetic is attached to tyrosine 
residue of JAK2. This stops STAT1a phosphorylation during IFN-γ signaling. SOCS-1 
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peptide antagonist binds to the KIR region of SOCS-1 that allows JAK2 phosphorylation, 
STAT1a phosphorylation and IFN-γ signaling pathway continues (Waiboci et al., 2007). 
Viruses have developed successful strategies to overcome the protective effects of 
interferons (Peng et al, 2008). HSV-1 infection can induce strong cytokine response in 
infected cells such as type I interferons (IFN-α & IFN-β). In keratinocytes HSV-1 
infection induces large amounts of IFNs as well as interleukins (IL) 1, 6, and chemokines 
(Sprecher et al., 1992).  In Human epidermal keratinocytes, INF-γ pretreatment induced 
HLA-DR expression and protected the cells from HSV-1 induced MHC class I down 
regulation (Mikloska et al., 1996). Antiviral effects of IFN-γ and IFN-γ peptide mimetic 
protected fibroblast (L929) cells from HSV-1 induced cytopathic effect, whereas 
keratinocyte (HEL-30) cell lines derived from C3H mice were not protected during the 
studies. Identical results were observed with cell lines PAM-212 and A2R1. PAM-212 
keratinocytes were not protected by IFN-γ during HSV-1 infection and A2R1 fibroblasts 
were protected through antiviral effect of the IFN-γ (Frey et al., 2009).  
CD8+ T-cells control HSV-1 infection by exocytosis of lytic granules or by 
secretion of cytokines IFN-γ and TNF-α (Sheridan et al., 2007). CD8+ T-cells also 
control the maintenance of latency and prevent reactivation of HSV-1. In ex-vivo cultures 
of latently infected ganglia, IFN-γ and granzyme B secreted by CD8+ T cells inhibited 
HSV-1 reactivation by degrading the ICP4 protein (crucial for lytic events) (Knickelbein 
et al., 2008). HSV-1 interferes with presentation of antigen on MHC class I molecules 
(Lacaille and Androlewicz, 1998), in such situation CTL responses would be insufficient 
for viral clearance. Since IFN-γ can up regulate MHC I expression (Mikloska et al., 
1996), this is critical in controlling HSV-1. 
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The hypothesis of this study is HSV-1 infection of murine fibroblasts and 
keratinocytes inhibits expression of MHC class I molecules during first 24 hours of 
infection. IFN-γ pretreatment of fibroblasts protected them from virus-induced inhibition 
of MHC class I expression, but did not protect keratinocytes.  
In the current study, fibroblast and keratinocyte cell lines derived from C3H mice 
(L929 fibroblasts and HEL-30 keratinocytes) and BALB/c mice (A2R1 fibroblasts and 
PAM-212 keratinocytes) responded differently to IFN-γ induction of MHC class I 
expression in HSV- 1 infected and IFN-γ pretreated cells. L929 and A2R1 cells expressed 
higher levels of MHC class I when treated with IFN-γ than keratinocytes. Different 
MOI’s were used to determine the appropriate dilution to use on the cell lines. 0.1 MOI 
was chosen because it has cytopathic effects on the cells. Frey et al., observed loss of cell 
viability (keratinocytes and fibroblasts) when infected for 48 hours with HSV-1 at 0.1 
MOI (Frey et al., 2009). It would be appropriate to observe for the MHC class I 
expression up to 24 hours post infection, since the cell viability will be lost by 48 hours 
post infection. 
The C3H mouse was partially resistant to infection by HSV-1 (Armerding and 
Rossiter, 1981). Type I IFN production has been proposed as a mechanism for resistance 
(Chmielarczyk et al., 1985). High levels of Type I IFNs were seen in exudates as soon as 
2-4 hours after infection (Engler et al., 1982). In contrast, BALB/c mice were not known 
to be resistant and they produce low levels of Type I IFNs (Watanabe et al., 1999). These 
two mouse cell lines were selected for the current study to identify if the IFN-γ 
pretreatment of control cells and infected cells leads to any variation in their resistance 
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pattern. Frey et al., observed that higher concentration of IFN-γ showed more protection 
for HSV-1 infection in fibroblast cell lines when compared using lower concentration of 
IFN-γ (Frey et al., 2009). Based on their data, a higher concentration of IFN-γ (100 
units/ml) has been used in this study. 
Immunofluorescence staining was performed for murine fibroblast cell lines 
(L929 and A2R1) at 6, 12, and 24 hours intervals post infection with HSV-1, to compare 
MHC class I expression. Image J software developed by NIH (National Institute of 
Health) was used for analyzing the images of MHC class I stained L929 and A2R1 cells. 
Images of the cells stained for actin and MHC class I were merged through Image J 
software. Flow cytometry technique was performed for all four cell lines (fibroblasts and 
keratinocytes) after 24 hours of infection. The reason for choosing 24 hours post infection 
time point was that immunocytochemistry results exhibited high MHC class I expression 
for IFN-γ pretreatment, and MHC class I expression was significantly decreased during 
HSV-1 infection, when compared to 6 and 12 hours post infection time point. However, 
for keratinocytes (HEL-30 (Figure 5), and PAM-212) immunolocalization was not 
possible because cells grew in clusters and the staining patterns in individual cells could 
not be analyzed by Image J software.  Immunofluorescence staining performed for 
keratinocytes HEL-30 (Figure 5) showed an unclear staining pattern. For better results 
the immunofluorescence staining for HEL-30 cells was repeated by trypsinizing the cells 
to separate them from clumping, resulting in less cell density and decrease in 
immunofluorescence intensity due to the loss of cells and disruption of cell membranes 
(Figure 6). Hence it was concluded that this method was not appropriate and flow 










Figure 5: Images of HEL-30 cells treated with antibodies for  (a) MHC class I 
(green), (b) actin (red), and (c) MHC class I and actin merged. Bar marker indicate 















Figure 6: Images of trypsinized HEL-30 cells treated with antibodies for  (a) MHC 
class I (green), (b) actin (red), and (c) MHC class I and actin merged. Bar marker 









MATERIALS AND METHODS 
Cell Culture: 
L929 cells from C3H mice and A2R1 cells of BALB/C mice are fibroblasts that 
populate the dermal layer of the skin. HEL-30 keratinocytes derived from C3H mice, (Dr. 
Janice Speshock, Wright Patterson Air Force Base), PAM-212 keratinocytes derived 
from BALB/c mice (American Type Culture Collection) and Vero cells (CCL-81, ATCC) 
were cultured in Dulbecco’s Modified Eagles Medium (DMEM) (Fisher Scientific, 
catalog # SH30243.01) supplemented with 10% heat-inactivated fetal calf serum, and 
1μl/ml gentamicin solution. The cells were grown on 100 mm
2
 tissue culture dishes and 
incubated in a humidified incubator at 37
o
 C with 5% CO2.  
Virus: 
Herpes Simplex Virus-1 strain Syn 17+ (Dr.Nancy Sawtell, Children’s Hospital 
Medical Center, Cincinnati, OH) was propagated in the lab. Vero cells were grown in a 
75cm² flask and a confluent monolayer was infected with HSV-1 at 0.1 multiplicity of 
infection (MOI). Cells were examined and harvested along with medium when cytopathic 
effects (cells rounding and detaching from the bottom of the flask) were evident after 3-5 
days of infection. Medium was stored as virus stock in 100 μl aliquots at -80⁰C. The 
number of plaque forming units (PFU) were calculated after performing a plaque assay 
on Vero cells. The virus was dispensed at 0.1 MOI in DMEM containing 2% calf serum 





C. The virus was left on the cells for 2 hours and then the culture medium was removed 
and replaced with fresh culture medium. Mock infected cells were treated in the same 
way, except 2% DMEM was used instead of 10% DMEM. For immunostaining, each cell 
line was added to sterile glass coverslips that were placed in 24 well plates and infected 
as previously described. 
IFN-γ pretreatment and virus infection of cells for immunocytochemistry:  
L929 and A2R1 cells were treated with IFN-γ (Peprotech, catalog # 315-05) at 
concentration of 100 units/ ml for 24 hours and then infected with HSV-1 at 0.1 MOI. A 
list of treated groups and infected groups were detailed in Table 1. 
 
Cell  group 
treated 
IFN-γ HSV-1 
Cell only _ _ 
Cell+ virus _ + 
Cell+ IFN-γ + _ 
Cell+ IFN-γ+ virus + + 
 
Table 1: List of treated cell groups for current study, specifying which groups are 
treated with IFN-γ and infected with HSV-1. 
 
Immunocytochemistry for MHC class I antigen and actin: 
         At the end of 6, 12, and 24 hours post infection time points, immunocytochemistry 





Immunocytochemistry procedure for L929 and HEL-30 cells: 
1) The cells were rinsed once with phosphate buffered saline (PBS), at room 
temperature (RT) and then the PBS was removed.  
2) 4% paraformaldehyde fixative (to preserve cell morphology) was added, and the cells 
were incubated at RT for 15 minutes.  
3) The paraformaldehyde fixative was removed, and quenched with sodium borohydride 
(1mg/ml) that was prepared just prior to use. The cells were incubated in this solution 
for 15 minutes at RT.  
4) The cells were then washed 3 times with PBS.  
5) 3% BSA (Bovine Serum Albumin) blocking solution was added to the cells and 
incubated at RT for 30 minutes. 
6) The primary biotin conjugated anti mouse MHC I (H-2Kk) (ebiosciences, catalog # 
13-5940-82) was prepared in the blocking buffer (diluted 1:100) and then it was 
applied to each coverslip.  
7) The coverslips were placed in a humidified chamber cell side down, and allowed to 
incubate at 4
o
 C overnight.  
8) Then coverslips were transferred back to their dishes, and washed three times with 
PBS.  
9) The secondary FITC conjugated streptavidin (ebiosciences, catalog # 11-4317-87) 
prepared in the blocking buffer (diluted 1:100) and Texas red conjugated phalloidin 
(Life technologies, catalog # T7471) for actin staining was prepared in the same 
blocking buffer  (diluted 1:100) were applied to each coverslip, and allowed to 
incubate for 2 hours at RT in the dark. 
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10) The coverslips were placed back into their dishes, and washed 3 times with PBS.  
11) The coverslips were mounted onto glass slides using liquid mounting medium- 
Vectashield (Vector Labs), and sealed with clear nail varnish.  
 
Immunocytochemistry procedure for A2R1 and PAM 212 cells: 
1) The cells were rinsed once with phosphate buffered saline (PBS), at room 
temperature (RT) and then the PBS was removed.  
2) 4% paraformaldehyde fixative was added, and the cells were incubated at RT for 15 
minutes.  
3) The paraformaldehyde fixative was removed, and quenched with sodium borohydride 
(1mg/ml) that was prepared just prior to use. The cells were incubated in this solution 
for 15 minutes at RT.  
4) The cells were then washed 3 times with PBS.  
5) 3% BSA blocking solution was added to the cells which were incubated at RT for 30 
minutes. 
6) Direct FITC conjugated anti mouse MHC I (H-2Kd/H-2Dd) (ebiosciences, catalog # 
11-5998-82) was prepared in the blocking buffer (diluted 1:100) and Texas red 
conjugated phalloidin (Life technologies, catalog # T7471) for actin staining was 
prepared in the same blocking buffer  (diluted 1: 100). Each antibody was applied to 
each coverslip, and allowed to incubate for 2 hours at RT in the dark. 
7) The coverslips were placed back into their dishes, and washed 3 times with PBS.  
8) The coverslips were mounted onto glass slides using liquid mounting medium- 
Vectashield (Vector Labs), and sealed with clear nail varnish.  
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Cells were observed under fluorescent microscope (Olympus Epi Fluorescence Spot 
Scope with real time color camera) and two images were taken per field. Two different 
filters (filter # 4 and 5) were used to capture images for one field, because each secondary 
antibody used has a different fluorescent label. Three fields were observed for each group 
per experiment, and three experiments were performed at each of the time points 
identified.  
Image J software by NIH (National Institute of Health) was used to measure MHC 
class I fluorescence intensity of L929 and A2R1 immunostained images. The pixel 
intensity was measured, and the mean fluorescent intensity was calculated using Image J 
software. At least three fields per group, and a minimum of three experiments were 





















































































































Table 2: List of antibodies and isotype controls used to stain cells for 
immunocytochemistry and flow cytometry. 
 
Flow Cytometry:  
Cells were harvested for flow cytometry at the 24 hours post infection time point 
and cells were detached from the plate with cell stripper solution (Cell grow, catalog # 
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25-056-CI). After assessing cell count and viability by trypan blue exclusion, 10
6
 cells 
per sample were transferred to 2 ml vial.  
 
Flow cytometry procedure for L929 and HEL-30 cells: 
1) To perform surface staining, samples were washed twice with 1% BSA, and blocked 
for 1 hour with 3% BSA.  
2) L929 and HEL 30 cells were stained with biotin conjugated anti mouse MHC I (H-
2Kk) (ebiosciences, catalog # 13-5940-82) that was prepared in the blocking buffer 
(diluted 1:100) and incubated for 1 hour at 4°C. 
3) Samples were washed twice with 1% BSA and stained with FITC conjugated 
streptavidin (ebiosciences, catalog # 11-4317-87) that was prepared in the blocking 
buffer (diluted 1:100) and incubated for 1 hour at 4°C.  
4) After incubation the samples were washed twice with 1% BSA.  
5) The final pellet was suspended in 1% sodium azide solution.  
Flow cytometry procedure for L929 and A2R1 and PAM-212 cells: 
1) L929 and HEL 30 cell samples were washed twice with 1% BSA, and blocked for 1 
hour with 3% BSA.  
2) Cells were stained with FITC conjugated anti mouse MHC I (H-2Kd/H-2Dd) 
(ebiosciences, catalog # 11-5998-82), that was prepared in the blocking buffer 
(diluted 1:100) and incubated for 1 hour at 4°C. 
3) After incubation the samples were washed twice with 1% BSA.  
4) The final pellet was suspended in 1% sodium azide solution.  
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For all the samples, flow cytometry was performed using C6 flow cytometer (BD 
Accuri), and analyzed with FCS Express 4 plus research edition.  
 
 
Statistical Analysis:  
Using Sigma Plot 12.0, statistical analysis was performed for the Image J 
analyzed fluorescence intensity values and mean fluorescence intensity values of flow 
cytometry. The values expressed are the Standard Error of the Mean (SEM). The Holm-





Immunocytochemistry for L929 fibroblast cells: 
HSV-1-infected L929 fibroblasts exhibited a decrease in MHC class I 
fluorescence intensity at 6 hours post infection (Figure 7) compared with untreated cells. 
When these cells were pretreated with IFN-γ, there was an increase in MHC class I 
expression in both infected and uninfected cells.  
After 12 hours of infection (Figure 8) there was a significant decrease in MHC 
class I fluorescence intensity in the virus infected cells, when compared with untreated 
cells. When these cells were pretreated, there was an increase in the MHC class I 
expression in both infected and uninfected cells. A decrease in cell density was observed 
in the HSV-1 infected group.   
After 24 hours of infection (Figure 8 & 10c), there was a significant decrease in 
MHC class I fluorescence intensity in the virus infected cells when compared with 
untreated cells. When these cells were pretreated with IFN-γ, there was an increase in the 
MHC class I expression both in infected and uninfected cells. During HSV-1 infection 
there was a decrease in the density of cells (Figure 9b & 9d).  
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  MHC class I stained                Actin stained                               Merged 
(a)                    
(b)    
(c)      
(d)    
 
Figure 7: Immunocytochemistry for L929- 6 hours post infection MHC class I 
stained( Green) and actin stained(Red) images: HSV-1 control (a), L929+HSV-1, (b) 
L929+ IFN- γ (c), L929+ IFN- γ + HSV-1(d). At 6 hours post infection, no difference 
in cell density was observed in between L929 uninfected cells and cells infected with 
HSV-1 virus. IFN-γ pretreated cells showed more fluorescent intensity when 









       MHC class I stained                 Actin stained                               Merged 
(a)            
(b)    
(c)    
(d)     
 
Figure 8: Immunocytochemistry for L929- 12 hours post infection MHC class I 
stained (Green) and actin stained (Red) images: HSV-1 control (a), L929+HSV-1, 
(b) L929+ IFN- γ (c), L929+ IFN- γ + HSV-1 (d). At 12 hours post infection, a 
decrease in cell density was observed in infected group when compared with 
uninfected group. IFN-γ pretreated and HSV-1 infected cells showed more 
fluorescent intensity when compared to infected cells. Bar markers indicate 50 μm. 
         





   MHC class I stained                 Actin stained                               Merged 
(a)     
(b)    
(c)    
(d)    
 
Figure 9: Immunocytochemistry for L929- 24 hours post infection MHC class I 
stained( Green) and actin stained(Red) images: HSV-1 control (a), L929+HSV-1, (b) 
L929+ IFN- γ (c), L929+ IFN- γ + HSV-1 (d). At 24 hours post infection, a decrease 
in cell density was observed in infected group when compared with uninfected 
group. IFN-γ pretreated and HSV-1 infected cells showed more fluorescent intensity 




Image J quantification of  MHC class I fluorescence intensity for L929 fibroblasts : 
When the mean fluorescence was measured and compared, there was a significant 
increase in the IFN-γ treated cells when compared with untreated cells (Figure 10).  
After 6, 12, and 24 hours of infection (Figure 10), the virus-infected cells showed 
a significant decrease in the immunofluorescence intensity, compared to control cells.  
After 24 hours of infection (Figure 10c), there was a significant decrease in 
immunofluorescence intensity both with virus infected, and uninfected cells. At 24 hours 
post infection, the IFN-γ pretreated expressed one fold increase in immunofluorescence 
intensity, compared with untreated cells. An increase in MHC class I fluorescence 
intensity was observed in IFN-γ pretreated, and HSV-1 infected L929 fibroblast cells, 











                              (a)                                                         (b) 
  
                                                                 (c) 
                                     
Figure 10: MHC class I fluorescent Intensity using image J program for L929 
fibroblasts at 6, 12, and 24 hours post infection. L929 fibroblasts at 6 hours post 
infection (a), L929 fibroblasts at 12 hours post infection (b), L929 fibroblasts at 24 
hours post infection (c). At 6, 12 and 24 hours post infection, the MHC class I 
fluorescence intensity increased significantly (P<0.001 by ANOVA) in the cells 







Immunocytochemistry for A2R1 fibroblast cells: 
 
HSV-1 infected L929 fibroblasts displayed a decrease in MHC class I 
fluorescence intensity at 6 hours post infection (Figure 11) compared with untreated cells.  
When these cells were pretreated with IFN-γ there was an increase in MHC class I 
expression in both infected and uninfected cell.  
After 12 hours of infection (Figure 12), IFN-γ pretreated cells showed an increase 
in the MHC class I expression both in infected and uninfected cells.  
After 24 hours of infection (Figure 13) there was a significant difference between 
the virus infected cells and the untreated cells. When these cells are pretreated with IFN-
γ, there was an increase in the MHC class I both in infected and uninfected cells. During 


















        MHC class I stained                 Actin stained                               Merged 
(a)    
(b)    
(c)    
(d)    
 
Figure 11: Immunocytochemistry for A2R1- 6 hours post infection MHC class I 
stained( Green) and actin stained(Red) images: HSV-1 control (a), A2R1+HSV-1, 
(b) A2R1+ IFN- γ (c), A2R1+ IFN- γ + HSV-1(d). At 6 hours post infection, no 
difference in cell density was observed in between A2R1 uninfected cells and cells 
infected with HSV-1 virus. IFN-γ pretreated cells showed more fluorescent intensity 
when compared with cells only. Bar markers indicate 50 μm. 






     MHC class I stained                 Actin stained                               Merged 
(a)    
(b)    
(c)    
(d)     
 
Figure 12: Immunocytochemistry for A2R1- 12 hours post infection MHC class I 
stained( Green) and actin stained(Red) images: HSV-1 control (a), A2R1+ HSV-1, 
(b) A2R1+ IFN-γ (c), A2R1+ IFN- γ + HSV-1(d). At 12 hours post infection, a 
decrease in cell density was observed in infected group when compared to 
uninfected group. IFN-γ pretreated and HSV-1 infected cells showed more 
fluorescent intensity when compared with infected cells. Bar markers indicate 50 
μm. 
        




      MHC class I stained                 Actin stained                               Merged 
(a)    
(b)    
(c)    
(d)    
 
Figure 13: Immunocytochemistry for A2R1- 24 hours post infection MHC class I 
stained( Green) and actin stained(Red) images: HSV-1 control (a), A2R1+ HSV-1, 
(b) A2R1+ IFN- γ (c), A2R1+ IFN- γ + HSV-1(d). At 24 hours post infection, a 
decrease in cell density was observed in infected group when compared to 
uninfected group. IFN-γ pretreated and HSV-1 infected cells showed more 






Image J quantification of  MHC class I fluorescence intensity for A2R1 fibroblasts : 
When the mean fluorescence was measured and compared, there was a significant 
increase in the IFN-γ treated A2R1 cells compared with untreated cells (figure 14).  
After 24 hours of infection (figure 14c), there was a significant decrease in the 
virus infected and uninfected cells. At 24 hours post infection, the IFN-γ pretreated cells 
expressed 2 fold increase in immunofluorescence, compared with untreated cells. HSV-1 
infected cells with IFN-γ pretreatment exhibited an increase in MHC class I fluorescence 



















(a)                                                       (b) 
            
                                                                   (c) 
                                       
Figure 14: MHC class I fluorescent Intensity using image J program for A2R1 
fibroblasts at 6, 12, and 24 hours post infection. A2R1 fibroblasts at 6 hours post 
infection (a), A2R1 fibroblasts at 12 hours post infection (b), A2R1 fibroblasts at 24 
hours post infection (c). At 6, 12 and 24 hours post infection, a significant increase in 
the MHC class I fluorescence intensity was observed (P<0.001 by ANOVA) in the 





Comparision of MHC class I fluorescence Intensity for fibroblasts at 6,12 and 24 
hours post infection:  
 For both fibroblast cell lines L929 (Figure 15) and A2R1 (Figure 16), at 6, 12, and 
24 hours post infection, a significant increase in the MHC class I fluorescence intensity 
was observed (P<0.001 by ANOVA) in the cells pretreated with IFN-γ and infected with 
HSV-1, compared with infected cells.  
L929 
 
Figure 15: Comparision of MHC class I fluorescent Intensity using image J program 
for L929  fibroblasts at 6. 12 and 24 hours post infection time points. At 6, 12 and 24 
hours post infection, a significant increase in the MHC class I fluorescence intensity 
was observed (P<0.001 by ANOVA) in the cells pretreated with IFN-γ and infected 









Figure 16: Comparision of MHC class I fluorescent Intensity using image J program 
for A2R1 fibroblasts at 6. 12 and 24 hours post infection time points. At 6, 12 and 24 
hours post infection, a significant increase in the MHC class I fluorescence intensity 
was observed (P<0.001 by ANOVA) in the cells pretreated with IFN-γ and infected 
with HSV-1 when compared to infected cells. 
 
MHC class I immunofluorescence intensity by flow cytometry: 
Flow cytometry was performed for all four cell lines, fibroblasts (A2R1 and 
L929) and keratinocytes (PAM-212 & HEL-30) at 24 hours post infection time point. 
Initially three experiments for each cell line were performed, taking the samples from 
same cell culture plate, and later three individual experiments were performed taking the 
samples from three different cell culture plates.  
For all the Flow cytometry graphs, isotype control (purple shaded) was included 
in the graph. Furthermore, statistical analysis for mean fluorescence values of the MHC 
class I was perfomed through One-way Anova using Sigma plot 12.0. All the groups 
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passed normality test and equal variance test. Significant differences were observed 
between all treated groups of fibroblasts and keratinocytes and the p value was <0.001. 
MHC class I immunofluorescence intensity by flow cytometry for L929 fibroblasts : 
        After 24 hours post infection in treated L929 fibroblasts, there was an increase in the 
MHC class I mean fluorescence intensity in IFN-γ pretreated cells. Cells pretreated with 
IFN-γ showed 4.5 fold increase in mean fluorescence compared with untreated cells 



















                           (a)                                                       (b) 
 
                            (c) 
         
Figure 17: Major histocompatibility complex class I antigen expression for L929 
fibroblasts through flow cytometry. Fluorescence-activated cell sorting analysis of  
HSV-1-infected cells (red) compared with uninfected cells (black) (a), IFN-γ 
pretreated and HSV-l-infected cells (blue) compared with IFN- γ pretreated and 
uninfected (orange) (b). IFN-γ–pretreated (orange) compared with untreated cells 
(black) (c). Isotype control (purple filled) was included in all groups but with no 
change in fluorescence. At 24 hours post infection, an increase in the MHC class I 
fluorescence intensity was observed in the cells pretreated with IFN-γ and infected 
with HSV-1 when compared with infected cells. Each histogram represents data for 
10
6





Statistical analysis was performed for mean fluorescence values of MHC class I 
fluorescence intensity using One-way Anova analysis using Sigma plot 12.0. There was a 
statistically significant difference between all treated groups for L929 fibroblasts. The p 
value is <0.001 (Figure 18). 
 
Figure 18: L929 fibroblasts- Graph for flow cytometry mean fluorescent values at 
24 hours post infection. Each bar represents average of three values. Values are 
taken from three different experiments. At 24 hours post infection, a significant 
increase in the MHC class I fluorescence intensity was observed (P<0.001 by 
ANOVA) in the cells pretreated with IFN-γ and infected with HSV-1 when 
compared to infected cells. 
 
MHC class I immunofluorescence intensity by flow cytometry for A2R1 fibroblasts: 
After 24 hours post infection, a significant increase in the MHC class I mean 
fluorescence intensity was observed in IFN-γ pretreated cells compared to untreated cells. 
IFN-γ pretreatment led to a 3 fold increase in mean fluorescence compared with untreated 
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cells (Figure 19 & 20). The HSV-1 infected cells were rescued from the infection upon 
IFN-γ pretreatment. 
 
                               (a)                                                      (b) 
 
                              (c) 
 
Figure 19: Major histocompatibility complex class I antigen expression for A2R1 
fibroblats through flow cytometry. Fluorescence-activated cell sorting analysis of  
HSV-1-infected cells (red) compared with uninfected cells(black) (a), IFN-γ 
pretreated and HSV-l-infected cells (blue) compared with IFN-γ pretreated and 
uninfected (orange) (b). IFN-γ–pretreated (orange) compared with untreated cells 
(black) (c). Isotype control (purple filled) was included in all groups but with no 
change in fluorescence.  At 24 hours post infection, an increase in the MHC class I 
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fluorescence intensity was observed in the cells pretreated with IFN-γ and infected 
with HSV-1 when compared with infected cells. Each histogram represents data for 
10
6
 cells. X axis = log fluorescence intensity, Y axis = number of events. 
 
Statistical analysis was performed for mean fluorescent values of MHC class I 
fluorescence intensity using One-way Anova analysis using Sigma plot 12.0. There was a 
statistically significant difference between all treated groups for A2R1 fibroblasts. The p 
value was <0.001 (Figure 20). 
 
Figure 20: A2R1 fibroblasts- Graph for flow cytometry mean fluorescent values at 
24 hours post infection. Each bar represents average of three values. Values are 
taken from three different experiments. At 24 hours post infection, a significant 
increase in the MHC class I fluorescence intensity was observed (P<0.001 by 
ANOVA) in the cells pretreated with IFN-γ and infected with HSV-1 when 






MHC class I immunofluorescence intensity by flow cytometry for PAM-212 
keratinocytes : 
After 24 hours post infection  in PAM-212  keratinocytes, IFN-γ pretreated cells 
expressed 1 fold increase in mean fluorescence compared with untreated cells. The HSV-
1 infected cells expressed relatively less intensity than the cell only. IFN-γ pretreated and 
HSV-1 infected cells showed a slight raise in intensity but not up to the basal level like 



















                              (a)                                                      (b) 
 
                              (c) 
    
Figure 21: Major histocompatibility complex class I antigen expression for PAM-
212 keratinocytes through flow cytometry. Fluorescence-activated cell sorting 
analysis of  HSV-1-infected cells (red) compared with uninfected cells (black) (a),   
IFN-γ pretreated and HSV-l-infected cells (blue) compared with IFN-γ pretreated 
and uninfected (orange) (b). IFN-γ– pretreated (orange) compared with untreated 
cells (black) (c). Isotype control (purple filled) was included in all groups but with 
no change in fluorescence. At 24 hours post infection, a significant increase in the 
MHC class I fluorescence intensity was observed in the cells pretreated with IFN-γ 
when compared with control cells. Each histogram represents data for 10
6
 cells. X 




Statistical analysis was performed for mean fluorescence values of MHC class I 
fluorescence intensity using One- way Anova analysis on Sigma plot 12.0. There was a 
statistically significant difference between all treated groups for PAM-212 keratinocytes. 
p value was <0.001 (Figure 22). 
 
 
Figure 22: PAM-212 keratinocytes- Graph for flow cytometry mean fluorescent 
values at 24 hours post infection. Each bar represents average of three values. 
Values are taken from three different experiments. At 24 hours post infection, a 
significant increase in the MHC class I fluorescence intensity was observed  




MHC class I intensity by Flow cytometry for HEL-30 keratinocytes : 
After 24 hourss of infection  in HEL-30 keratinocytes, IFN-γ pretreated cells 
expressed one fold increase in mean fluorescence compared to the untreated cells; this 
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was similar to the results obtained for other keratinocyte PAM-212. IFN-γ pretreated and 
HSV-1 infected cells expressed an increase in fluorescence intensity compared with 
HSV-1 infected cells, but this increase was not up to the basal level of untreated cells and 
the cells were not protected from the infection. Both keratinocytes expressed similar 
pattern of MHC class I expression for the test groups but HEL-30 cells showed more 




















                                 (a)                                                                (b) 
             
                                   (c) 
       
                         
Figure 23: Major histocompatibility complex class I antigen expression for HEL-30 
keratinocytes through flow cytometry. Fluorescence-activated cell sorting analysis 
of  HSV-1-infected cells (red) compared with uninfected cells (black) (a), IFN-γ 
pretreated and HSV-l-infected cells (blue) compared with IFN-γ pretreated and 
uninfected (orange) (b). IFN-γ– pretreated (orange) compared with untreated cells 
(black) (c). Isotype control (purple filled) was included in all groups but with no 
change in fluorescence. At 24 hours post infection, a significant increase in the MHC 
class I fluorescence intensity was observed in the cells pretreated with IFN-γ when 
compared to control cells. Each histogram represents data for 10
6
 cells. X axis = log 




Statistical analysis was performed for mean fluorescence values of the MHC class 
I fluorescence intensity using One- way Anova analysis on Sigma plot 12.0. There was a 
statistically significant difference between all treated groups for HEL-30 keratinocytes. p 




Figure 24: HEL-30 keratinocytes- Graph for flow cytometry mean fluorescent 
values at 24 hours post infection. Each bar represents average of three values. 
Values are taken from three different experiments. At 24 hours post infection, a 
significant increase in the MHC class I fluorescence intensity was observed (P<0.001 







 The flow cytometry data for the fibroblasts and keratinocytes was summarized in 
Table 3. In this table, treated and infected groups were compared with contorl group and 
indicated the variations in MHC class I fluorescence intensity. 
 
 A2R1 L929 PAM-212 HEL-30 
Cell+ virus Decreased Decreased Decreased Decreased 
Cell+ IFN-γ Increased Increased Increased Increased 
Cell+ IFN-γ + virus Increased Increased Decreased Decreased 
 
Table 3: Flow cytometry results summary for Fibroblasts (L929 & A2R1) and 






In the current study, a difference was observed in the viral effects of IFN-γ on 
fibroblast (L929) compared to keratinocyte (HEL-30) cell lines derived from C3H mice. 
L929 fibroblasts were rescued from HSV-1 induced down regulation of MHC class I 
(Figure 17 & 18) while the HEL-30 keratinocytes were not protected (Figure 23 & 24). 
The induction of MHC class I by IFN-γ following HSV-1 infection of another murine 
keratinocyte cell line derived from BALB/c mice (PAM-212), was similar to that seen in 
HEL-30 cells (Figure 21 & 22). Similar to L929 cells, a fibroblast cell line from BALB/c 
mice (A2R1) was protected from HSV-1 induced down regulation of MHC class I 
(Figure 19 & 20). 
Keratinocytes activated by IFN-γ pretreatment exhibited MHC class I, MHC class 
II and ICAM-1 expression (Mikloska et al., 1996; Mikloska and Cunningham, 1998). 
These factors are important for cell survival during infection. If IFN-γ action is inhibited, 
virus can readily infect the cells. Frey et al.,(2009) observed that IFN-γ pretreatment 
permitted survival of fibroblasts when infected with HSV-1 at 0.1 MOI. Fibroblasts and 
keratinocytes lost viability by 48 hours after infection with 0.1 MOI of HSV-1. Frey also 
observed an increase in expression of SOCS-1, which is a negative regulator of IFN-γ, 
during HSV-1 infection in keratinocytes (Frey et al., 2009).  In the current study, HSV-1 
infected keratinocytes alone expressed significantly less MHC class I, compared with 
untreated cells by 24 hours post infection (Figure 21, 22, 23 & 24). Down 
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regulation of MHC class I expression during virus infection probably results from cell 
death during infection. To account for this, a cell viability count should be performed 
before analyzing the samples in flow cytometry.  In the current study, virus infected cells 
(Figure 7(b), 9(b)) expressed less MHC class I seen in immunofluorescence stained 
images compared with cell only (Figure 7(a), 9(a)). There was a decrease in MHC class I 
expression in virus infected cells.  
In this study, Immunofluorescent staining for expression of MHC class I 
molecules in IFN- treated and HSV-1 infected cells was performed using two methods, 
namely, immunocytochemistry and flow cytometry.  Only the fibroblast cell lines could 
be examined by both methods. To analyze immunofluorescence intensity of 
immunocytochemistry images, Image J software was used.  
In fact of the methods, at 24 hour post infection of L929 cells, the IFN-γ treated 
cells increased expression of MHC class I. A 4.5 fold increase in fluorescence intensity 
was observed with flow cytometry (Figure 17 & 18), whereas 1.5 fold increase was seen 
with Image J software quantification of immunofluorescence, compared to untreated cells 
(Figure 10(c)).  
A similar pattern resulted with A2R1 fibroblasts at 24 hours post infection. The 
IFN-γ treated cells showed 3 fold increase in fluorescence intensity by flow cytometry 
(Figure 19 & 20), whereas a 1.5 fold increase was seen with Image J software 
quantification of immunofluorescence, compared with untreated cells (Figure 14(c)). 
Similar patterns of MHC class I expression was observed using both Image J and flow 
cytometry quantifications, validating the use of Image J analysis of fluorescence intensity 
for such studies.  
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Currently, various laboratories are using Image J as the standard software for 
quantification of MHC class I immunofluorescence. For example, surface MHC class I 
levels were quantified during coxsackie virus B3 (CVB3) infection using Image J 
software (Christopher et al., 2007).  
In conclusion, the current results support the data presented by Frey et al., (2009). 
Fibroblasts are protected against HSV-1 infection by treating the cells with IFN-γ, and 
keratinocytes are refractory to IFN-γ treatment. The MHC I expression can be 
successfully up regulated in normal and infected cells of L929 (Figure 17 & 18) and 
A2R1 fibroblasts (Figure 19 & 20)). IFN-γ can also up regulate MHC class I expression 
in keratinocytes (PAM-212 (Figure 21 & 22) and HEL-30 (Figure 23 & 24)), but during 
HSV-1 infection, the SOCS-1 levels increased in keratinocytes (Frey et al., 2009), which 
can interrupt the IFN-γ signaling pathway.  
The current results indicate that fibroblasts respond well to IFN-γ treatment, since 
the fibroblast cells (L929 & A2R1) expressed an average of 3.5 fold increase in MHC 
class I expression when treated with IFN-γ, whereas keratinocytes expressed a 1-fold 
increase. The possible reasons can be the expression of higher levels of endogenous 
SOCS-1 in keratinocytes when compared with fibroblast cells (Frey et al., 2009). Frey et 
al. (2009) also observed that IFN-γ itself up regulates SOCS-1 expression in 
keratinocytes. In his study SOCS inhibitors were used in order to increase the cell 
survival in IFN-γ treated and HSV-1 infected keratinocytes (Frey et al., 2009). 
In future studies, use of SOCS-1 inhibitors along with IFN-γ treatments for 
keratinocytes would be appropriate to increase the MHC class I expression during HSV-1 
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infection. Identification of the mRNA levels of the MHC class I protein through the RT- 
PCR technique would validate the results.  
HSV-1 evades immune system through SOCS-1 by blocking the JAK/STAT 
pathway; this is an efficient way to suppress the host defense reaction (Miller et al., 
1998). HEL-30 keratinocytes and PAM-212 keratinocytes express higher levels of 
endogenous SOCS-1 than fibroblast cells (Frey et al., 2009). A similar mechanism was 
observed by Yokota et al. (2004) during studies with SOCS-3 and demonstrated that IFN-
α signal transduction pathway was blocked in JAK phosphorylation site in the same way 
as SOCS-1. Western blot revealed that STAT1 phosphorylation was inhibited in SOCS-3 
over expressed FL cells. These results showed that HSV-1 also stimulates SOCS-3 
expression as its anti-viral function (Yokota et al., 2004).  
Although SOCS proteins play an important role in inhibition of host anti-viral 
defense mechanisms, it is not the only strategy stimulated by HSV-1. Lin et al. (2004) 
demonstrated that other strategies which do not depend on IFN-γ, can be used by HSV-1 
to defeat host antiviral defense. They observed that the HSV-1 immediate early protein- 
ICP0 and virus shut off protein together act against immune response. Therefore, further 
research is required to verify which of these strategies are more effective to block host 
immune response by HSV-1. This could be considered as one limitation on this approach 
and would be an appropriate subject for future studies. 
In addition, HSV-1 blocks the signaling effects of type 1 interferons by reducing 
the effects of the double-stranded RNA-activated protein kinase (PKR) (Melroe et al., 
2004).  Frey et al. (2009) mentioned that treatment of cells with IFN-β and IFN-γ inhibits 
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viral replication and mRNA accumulation to a greater extent than treatment with either 
IFN alone. IFN-γ can also be used in combination of type 1 interferons.    
For future studies, it would be of interest to verify whether the combinations of 
interferons exert changes in SOCS-1 levels through Western blot technique, assessing 
mRNA levels using RT-PCR, while simultaneously measuring MHC class I expression 
levels.  
Frey et al. (2009) observed that keratinocytes (HEL-30) were refractory to IFN-γ 
induction of an antiviral state during HSV-1 infection. Refractiveness of keratinocytes to 
IFN-γ was attributed to the production of SOCS-1. Both IFN-γ and HSV-1 were found to 
up regulate production of SOCS-1 in keratinocytes. Identifying whether SOCS-1 
inhibitors would permit the keratinocytes to express any type I interferon response and 
protect the cells from HSV-1 induced MHC class I down regulation would be analyzed. 
Recent studies have demonstrated that keratinocytes are capable of producing pro-
inflammatory cytokines in response to virus infection (Hukkanen et al., 2002). Production 
of IL-1β, TNF-α and IL-6 was observed during HSV-1 infection of primary keratinocytes 
from BALB/C and C57Bl/6 mice (Sprecher and Becker, 1992). Fibroblasts also have 
immune functions. Particularly, fibroblasts secrete pro-inflammatory cytokines that 
mediate extravasation of leukocytes (McGettrick et al., 2009). Determination of these 
secretory cytokines prior and post virus infection would give further insight on 
inflammatory response following virus infection and the influence of these cytokines on 
the MHC class I expression levels. A brief experimental design is proposed for measuring 
type 1 interferons during HSV-1 infection in few steps: 
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1. Infected cells could be lysed, and IFN-β levels measured using a murine IFN-β 
ELISA kit (Ahmed et al., 2010). IFN-α can be measured using IFN-α ELISA kit 
(Fujisawa et al., 1997). Using cell lysates for measuring IFN levels would show the 
IFN response to early infection. Culture supernatant fluids of fibroblast and 
keratinocyte cells can also be analyzed for IFN-β, and IFN-α production (Fujisawa et 
al., 1997).  
2. Measuring the IFN levels before infection would show the actual amounts produced 
post infection. 
3. Fluorescently labeled anti mouse IFN antibodies can be used if the ELISA kits are not 
sensitive enough to detect interferons. 
4. Western blot technique can be used to measure protein levels (interferon levels). 
5. Further validations can be done by detecting mRNA levels for these interferons 


















1. Akhtar J, Tiwari V, Oh MJ, et al. (2008).  HVEM and nectin-1 are the major   
mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival 
epithelium. Invest Ophthal mol Vis Sci, 49(9); 4026–35. 
2. Ansel, J., Perry, P., Brown, J., Damm, D., Phan, T., Hart, C., Luger, T., and 
Hefeneider, S. (1990). Cytokine modulation of keratinocyte cytokines. J Invest 
Dermatol, 94; 101S-107S. 
3.  Armerding, D., and Rossiter, H. (1981). Induction of natural killer cells by 
herpes-simplex virus type 2 in resistant and sensitive inbred mouse strains. 
Immunobiology, 158; 369-379. 
4. Bach, E. A., Aguet, M., Schreiber, R. D. (1997). The IFN gamma receptor: a 
paradigm for cytokine receptor signaling. Annu Rev Immunol, 15; 563-91. 
5. Chmielarczyk, W., Domke, I., and Kirchner, H. (1985). Role of interferon in the 
resistance of C3H/HeJ mice to infection with herpes simplex virus. Antiviral Res, 
5; 55-59. 
6. Christopher T. Cornell, William B. Kiosses, Stephanie Harkins and J. Lindsay 
Whitton. (2007). Coxsackievirus B3 Proteins Directionally Complement Each 
Other To Downregulate Surface Major Histocompatibility Complex Class I. J 
Virol, 81; 6785–6797.  
7. Engler, H., Zawatzky, R., Kirchner, H., and Armerding, D. (1982). Experimental 
infection of inbred mice with herpes simplex virus. IV. Comparison of interferon 
production and natural killer cell activity in susceptible and resistant adult mice. 
Arch Virol, 74; 239-247. 
56 
 
8. Favoreel, H.W., Nauwynck, H.J., and Pensaert, M.B. (2000). Immunological 
hiding of herpesvirus-infected cells. Arch Virol, 145; 1269-1290.  
9. Fujisawa, H., Kondo, S., Wang, B., Shivji, G. M., & Sauder, D. N. (1997). The 
expression and modulation of IFN-alpha and IFN-beta in human keratinocytes. J 
Interferon & Cytokine Res, 17(12); 721-725. 
10. Frey, K. G., Ahmed, C. M., Dabelic, R., Jager, L. D., Noon-Song, E. N., Haider, 
S. M., & Bigley, N. J. (2009). HSV-1-induced SOCS-1 expression in 
keratinocytes: Use of a SOCS-1 antagonist to block a novel mechanism of viral 
immune evasion. J Immunol, 183(2); 1253-1262.  
11. Frey, K. G. (2009). (Unpublished Ph.D. Thesis). Wright State University. 
12. Gregory T. Melroe, Neal A. DeLuca and David M. Knipe. (2004). Herpes 
Simplex Virus 1 Has Multiple Mechanisms for Blocking virus-Induced Interferon 
Production. J Virol, 78(16); 8411-20. 
13. Hukkanen, V., Broberg, E., Salmi, A., and Eralinna, J.P. (2002). Cytokines in 
experimental herpes simplex virus infection. Int Rev Immunol, 21; 355-371. 
14. Isaacs, A., Lindermann, J. (1957). Virus interference. I. The interferon Proc. R. 
Soc. Lond. B Biol Sci, 147; 258-26. 
15. Jaroszeski MJ, Radcliff G. (1999). Fundamentals of flow cytometry.  Mol 
Biotechnol, 11(1); 37-53.  
16. Knickelbein, J., Khanna, K., Yee, M., Catherine, B., Kinchington, P., Hendricks 
R. (2008). Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 




17. Lacaille, V.G., and Androlewicz, M.J. (1998). Herpes simplex virus inhibitor 
ICP47 destabilizes the transporter associated with antigen processing (TAP) 
heterodimer. J Biol Chem, 273; 17386-17390. 
18. Ladwein M, Rottner K. (2008). On the Rho'd: the regulation of membrane 
protrusions by Rho-GTPases. FEBS Lett, 582(14); 2066–74. 
19. Lin, R., R.S. Noyce, S. E. Collins, R. D. Everett, and K. L. Mossman. (2004).The 
herpes simplex virus ICP0 ring finger Domain Inhibits IRF3- and IRF7- mediated 
activation of interferon-stimulated Genes. J Virol, 78; 1675-1684. 
20. Marshall DS, Linfert DR, Draghi A, McCarter YS, Tsongalis GJ. (2001). 
Identification of herpes simplex virus genital infection: comparison of a multiplex 
PCR assay and traditional viral isolation techniques. Mod Pathol, 14; 152–156. 
21. McGettrick, H.M., Smith, E., Filer, A., Kissane, S., Salmon, M., Buckley, C.D., 
Rainger, G.E., and Nash, G.B. (2009). Fibroblasts from different sites may 
promote or inhibit recruitment of flowing lymphocytes by endothelial cells. Eur J 
Immunol, 39; 113-125.  
22. Mellman I and Steinman RM. (2001). Dendritic cells: specialized and regulated 
antigen processing machines. Cell, 106; 255–25. 
23. Melroe, G.T., DeLuca, N.A., and Knipe, D.M. (2004). Herpes simplex virus 1 has 
multiple mechanisms for blocking virus-induced interferon production. J Virol, 
78; 8411-8420. 
24. Mikloska, Z., and Cunningham, A.L. (1998).  Herpes simplex virus type 1 
glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte 
58 
 
cytotoxicity in HLA-DR expressing human epidermal keratinocytes. J Gen Virol, 
79; 353-361.  
25. Mikloska, Z., Bosnjak, L., and Cunningham, A.L. (2001). Immature monocyte-
derived dendritic cells are productively infected with herpes simplex virus type 1. 
J Virol, 75; 5958-5964.   
26. Mikloska, Z., Danis, V.A., Adams, S., Lloyd, A.R., Adrian, D.L., and 
Cunningham, A.L. (1998). In vivo production of cytokines and beta (C-C) 
chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-
infected keratinocytes contribute to their production. J Infect Dis, 177; 827-838.  
27. Miller, D. M., B. M. Rahill, J. M. Boss, M. D. Lairmore, J. E. Durbin, J. W. 
Waldman, and D. D. Sedmak. (1998). Human cytomegalovirus inhibits major 
histocompatibility complex class II expression by disruption of the Jak/Stat 
pathway. J Exp Med, 187; 675-683. 
28. Minami M., Kita M., Yan X., Yamamoto T., Iida T., Sekikawa K., Iwakura Y., 
Imanishi J. (2002). Role of IFN-γ and Tumor Necrosis Factor-α in Herpes 
Simplex Virus Type 1 Infection. J Interferon  & Cytokine Res, 22(6); 671-676. 
29. Mikloska, Z., Kesson, A.M., Penfold, M.E., and Cunningham, A.L. (1996). 
Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in 
cultured epidermal keratinocytes treated with interferon-gamma. J Infect Dis, 173; 
7-17. 
30. Minagawa, H., Hashimoto, K., and Yanagi, Y. (2004). Absence of tumour 
necrosis factor facilitates primary and recurrent herpes simplex virus-1 infections. 
J Gen Virol, 85; 343-347. 
59 
 
31. Nicola, A.V., Hou, J., Major, E.O., and Straus, S.E. (2005). Herpes simplex virus 
type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent 
endocytic pathway. J Virol, 79; 7609-7616. 
32. Nina Korzeniewski, Rolando Cuevas, Anette Duensing, and Stefan Duensing. 
(2010). Daughter Centriole Elongation Is Controlled by Proteolysis. Mol Biol 
Cell, 21; 3942-3951.  
33. Norkin, L. C. (2010). Virology (First ed.). Washington, D.C.: ASM Press, pp 471. 
34. Oh MJ, Akhtar J, Desai P, Shukla D. (2010). A role for heparan sulfate in viral 
surfing. Biochem Biophys Res Commun, 391(1); 176–81. 
35. Pena KC, Adelson ME, Mordechai E, Blaho JA. (2010). Genital herpes simplex 
virus type 1 in women: detection in cervicovaginal specimens from gynecological 
practices in the United States. J Clin Microbiol, 48; 150–153. 
36. Perera, R.J., Koo, S., Bennett, C.F., Dean, N.M., Gupta, N., Qin, J.Z., and 
Nickoloff, B.J. (2006). Defining the transcriptome of accelerated and replicatively 
senescent keratinocytes reveals links to differentiation, interferon signaling, and 
Notch related pathways. J Cell Biochem, 98; 394-408. 
37. Raftery MJ, Behrens CK, Miller A, Krammer PH, Walczak H, Schnrich G. 
(1999). Herpes Simplex Virus Type 1 Infection of Activated Cytotoxic T Cells. J 
Exp Med, 190(8); 1103–1113. 
38. Rupert Abele and Robert Tempe. (2004). The ABCs of Immunology: Structure 
and Function of TAP, the Transporter Associated with Antigen Processing. J 
Physiology, 19; 216-24. 
60 
 
39. Sarah Salameh, Urmi Sheth, and Deepak Shukla. Early Events in Herpes Simplex 
Virus Lifecycle with Implications for an Infection of Lifetime. (2012). J Virol, 6; 
1–6. 
40. Shahin, V., Hafezi, W., Oberleithner, H., Ludwig, Y., Windoffer, B., Schillers, 
H., and Kuhn, J.E. (2006). The genome of HSV-1 translocates through the nuclear 
pore as a condensed rod-like structure. J Cell Sci, 119; 23-30.  
41. Shukla D, Spear PG. (2001). Herpesviruses and heparan sulfate: an intimate 
relationship in aid of viral entry. J Clin Invest, 108(4); 503–10.  
42. Sheridan, B. S., Knickelbein, J. E., Hendricks, R. L. (2007). CD8 T cells and 
latent herpes simplex virus type 1: keeping the peace in sensory ganglia. Expert 
Opinion on Biological Therapy, 7(9); 1323-31.  
43. Sprecher, E., and Becker, Y. (1992). Detection of IL-1 beta, TNF-alpha, and IL-6 
gene transcription by the polymerase chain reaction in keratinocytes, Langerhans 
cells and peritoneal exudate cells during infection with herpes simplex virus-1. 
Arch Virol, 12; 253-269. 
44. Tomazin R, van Schoot NE, Goldsmith K, Jugovic P, Sempe P, et al. (1998). 
Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J 
Virol, 72; 2560–2563. 
45. Taylor, T.J., Brockman, M.A., McNamee, E.E., and Knipe, D.M. (2002). Herpes 
simplex virus. Front Bio Sci, 7; 752-64. 
46. Lilly Cheng Immergluck, Miriam S. Domowicz, Nancy B. Schwartz and Betsy C. 
Herold. (1998). Viral and cellular requirements for entry of herpes simplex virus 
type 1 into primary neuronal cells. J Virol, 79; 549–559. 
61 
 
47. Waiboci, L. W., C. M. Ahmed, M. G. Mujtaba, L. O. Flowers, J. P. Martin, M. I. 
Haider, and H. M. Johnson. (2007). Both the suppressor of cytokine signaling-1 
(SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 
autophosphorylation site: implications for the development of a SOCS-1 
antagonist. J Immunol, 178; 5058-5068. 
48. Watanabe, D., Adachi, A., Tomita, Y., Yamamoto, M., Kobayashi, M., and 
Nishiyama, Y. (1999). The role of polymorphonuclear leukocyte infiltration in 
herpes simplex virus infection of murine skin. Arch Dermatol Res, 291; 28-36. 
49. Wharton, S.B., Meyers, N.L., and Nash, A.A. (1995). Experimental herpes 
simplex virus type 1 (HSV-1) infection of the spinal cord and dorsal root ganglia. 
Neuropathol Appl Neurobiol, 21; 228-237. 
50. Whitley, R.J., and Roizman, B. (2001). Herpes simplex virus infections. Lancet, 
357; 1513-1518. 
51. Yokota, S., N. Yokosawa, T. Okabayashi, T. Suztani, S. Miura, K. Jimbow, and 
N. Fujii. (2004). Induction of suppressor of cytokine signaling-3 by herpes 
simplex type-1 contributes to inhibition of the interferon signaling pathway. J 
Virol, 78; 6282-6282 
 
 
